Therapeutic Effect of Trastuzumab in Neoadjuvant-Treated HER2-Positive Breast Cancer with Low Infiltrating Level of Tumor-Infiltrating Lymphocytes

PURPOSE: The aim of the present study was to investigate the effect of trastuzumab on the pathological complete response (pCR) rate and event-free survival (EFS) in neoadjuvant-treated HER2-positive breast cancer with a low infiltrating level of tumor-infiltrating lymphocytes (TILs). PATIENTS AND ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shiwei, Mou, Exian, Zeng, Shiyan, Wang, Lu, Dong, Hao, Ji, Juan, Yang, Hong, Li, Junjie, Wang, Hao, Li, Hui, Xu, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221413/
https://www.ncbi.nlm.nih.gov/pubmed/32440212
http://dx.doi.org/10.2147/CMAR.S248071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221413/
https://www.ncbi.nlm.nih.gov/pubmed/32440212
http://dx.doi.org/10.2147/CMAR.S248071

Ejemplares similares